Chemours (CC) Institutional Ownership

76.26% of Chemours' stock is owned by institutional investors. Learn more on CC's institutional investor holdings.

Of the 309 institutional investors that purchased Chemours' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cooper Creek Partners Management LLC ($3.98M), Millennium Management LLC ($2.29M), Ameriprise Financial Inc. ($2.17M), Scopia Capital Management LP ($2.07M), Norges Bank ($1.92M), Vanguard Group Inc. ($1.85M), and Balyasny Asset Management L.P. ($1.76M).

Institutional investors have bought a total of 35,551,596 shares in the last 24 months. This purchase volume represents approximately $480.15M in transactions.

Of the 117 institutional investors that sold Chemours' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Marshall Wace LLP ($4.71M), Appian Way Asset Management LP ($3.24M), Millennium Management LLC ($2.92M), JPMorgan Chase & Co. ($2.15M), Luminus Management LLC ($1.70M), UBS Group AG ($1.17M), and Barclays PLC ($701.33K).

Institutional investors have sold a total of 25,957,302 shares in the last 24 months. This volume of shares sold represents approximately $367.03M in transactions.